Search - tctmd.com

Displaying 241 - 260 of 644

Sort: Relevancy | Date

News Daily News

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

Caitlin E. Cox

December 30, 2022

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS

Todd Neale

December 01, 2022

News Daily News

Psychosocial Risk Affects AVR Recovery, Merits Heart Team Consideration

L.A. McKeown

November 24, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

Presentation TCT 2022

Catheter-Based Management of Infectious Endocarditis

Presenter: Abdallah El Sabbagh

September 19, 2022

Presentation TCT 2022

R Sided Clot in Transit

Presenter: Matthew Finn

September 19, 2022

Presentation TCT 2022

Getting Smart With PE Diagnosis: The Role of AI

Presenter: Robert Lookstein

September 19, 2022

Presentation TCT 2022

The PERT Effect: How to Establish a Multdisciplinary Care Team for PE

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

FLASH 800 and clinical implications

Presenter: Catalin Toma

September 19, 2022

Presentation TCT 2022

Why intervene in submassive patients

Presenter: Wissam Jaber

September 19, 2022

Presentation TCT 2022

FlowTriever in high-risk patients

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

Introduction to the PE/VTE landscape and critical unmet needs

Presenter: Shon Chakrabarti

September 19, 2022

Presentation TCT 2022

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

Presenter: Catalin Toma

September 19, 2022

Presentation TCT 2022

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Presenter: Teresa Carman

September 19, 2022

Presentation TCT 2022

Clinical RV Assessment in PE: Is it Hocus Pocus or Can We Standardize Echo Parameters?

Presenter: Rebecca Hahn

September 19, 2022

Presentation TCT 2022

Hemodynamics of PE: Modeling the RV

Presenter: Daniel Burkhoff

September 19, 2022

Advertisement

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS

Psychosocial Risk Affects AVR Recovery, Merits Heart Team Consideration

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

November 2022 News Roundup

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Catheter-Based Management of Infectious Endocarditis

R Sided Clot in Transit

Getting Smart With PE Diagnosis: The Role of AI

The PERT Effect: How to Establish a Multdisciplinary Care Team for PE

FLASH 800 and clinical implications

Why intervene in submassive patients

FlowTriever in high-risk patients

Introduction to the PE/VTE landscape and critical unmet needs

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Clinical RV Assessment in PE: Is it Hocus Pocus or Can We Standardize Echo Parameters?

Hemodynamics of PE: Modeling the RV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content